Lawrence Leiter
Lawrence Leiter
Verified email at smh.ca
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 131 (4), e29-e322, 2015
27324*2015
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
21652*2012
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ...
New England Journal of Medicine 369 (14), 1317-1326, 2013
33812013
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes
SP Marso, SC Bain, A Consoli, FG Eliaschewitz, E Jódar, LA Leiter, ...
N Engl J Med 375, 1834-1844, 2016
28782016
Effects of combination lipid therapy in type 2 diabetes mellitus
ACCORD Study Group
New England Journal of Medicine 362 (17), 1563-1574, 2010
28472010
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ...
New England Journal of Medicine 380 (4), 347-357, 2019
23382019
Effects of dalcetrapib in patients with a recent acute coronary syndrome
GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ...
New England Journal of Medicine 367 (22), 2089-2099, 2012
18702012
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome …
TA Zelniker, SD Wiviott, I Raz, K Im, EL Goodrich, MP Bonaca, ...
The Lancet 393 (10166), 31-39, 2019
12132019
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management
ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ...
European heart journal 36 (17), 1012-1022, 2015
10322015
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult–2009 recommendations
J Genest, R McPherson, J Frohlich, T Anderson, N Campbell, ...
Canadian Journal of Cardiology 25 (10), 567-579, 2009
9812009
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult
TJ Anderson, J Grégoire, RA Hegele, P Couture, GBJ Mancini, ...
Canadian Journal of Cardiology 29 (2), 151-167, 2013
9352013
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
8132019
Effect of valsartan on the incidence of diabetes and cardiovascular events
NAVIGATOR Study Group
New England Journal of Medicine 362 (16), 1477-1490, 2010
8012010
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised …
WT Cefalu, LA Leiter, KH Yoon, P Arias, L Niskanen, J Xie, DA Balis, ...
The Lancet 382 (9896), 941-950, 2013
7522013
Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein
DJA Jenkins, CWC Kendall, A Marchie, DA Faulkner, JMW Wong, ...
Jama 290 (4), 502-510, 2003
7172003
Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein
DJA Jenkins, CWC Kendall, A Marchie, DA Faulkner, JMW Wong, ...
Jama 290 (4), 502-510, 2003
7172003
2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult
TJ Anderson, J Grégoire, GJ Pearson, AR Barry, P Couture, M Dawes, ...
Canadian Journal of Cardiology 32 (11), 1263-1282, 2016
6802016
Cholesterol lowering in intermediate-risk persons without cardiovascular disease
S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ...
New England Journal of Medicine 374 (21), 2021-2031, 2016
6792016
1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.
S Meltzer, L Leiter, D Daneman, HC Gerstein, D Lau, S Ludwig, JF Yale, ...
CMAJ: Canadian Medical Association journal= journal de l'Association …, 1998
6391998
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino Sr, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
6282018
The system can't perform the operation now. Try again later.
Articles 1–20